BMC Psychiatry (Nov 2005)

Bright light treatment of depression for older adults [ISRCTN55452501]

  • Knickerbocker Nancy C,
  • Elliott Jeffrey A,
  • Kripke Daniel F,
  • Loving Richard T,
  • Grandner Michael A

DOI
https://doi.org/10.1186/1471-244X-5-41
Journal volume & issue
Vol. 5, no. 1
p. 41

Abstract

Read online

Abstract Background The incidence of insomnia and depression in the elder population is significant. It is hoped that use of light treatment for this group could provide safe, economic, and effective rapid recovery. Methods In this home-based trial we treated depressed elderly subjects with bright white (8,500 Lux) and dim red ( Results Eighty-one volunteers, between 60 and 79 years old, completed the study. Both treatment and placebo groups experienced mood improvement. Average GDS scores improved 5 points, the Hamilton Depression Rating Scale (HDRS) 17 scores (extracted from the self-rated SIGH-SAD-SR) improved 6 points. There were no significant treatment effects or time-by-treatment interactions. No significant adverse reactions were observed in either treatment group. The assays of urine and saliva showed no significant differences between the treatment and placebo groups. The healthy control group was active earlier and slept earlier but received less light than the depressed group at baseline. Conclusion Antidepressant response to bright light treatment in this age group was not statistically superior to placebo. Both treatment and placebo groups experienced a clinically significant overall improvement of 16%.